| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |